Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
xjNeee1BShTvy7xw
